These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28061318)
1. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2. Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318 [TBL] [Abstract][Full Text] [Related]
2. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4]. Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291 [No Abstract] [Full Text] [Related]
3. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma. Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway. Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712 [TBL] [Abstract][Full Text] [Related]
5. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg]. Li YW; Yang HZ; Ke QS; Chen W; Chen XJ Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling. Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation. Wang S; Chen Z; Hu C; Qian F; Cheng Y; Wu M; Shi B; Chen J; Hu Y; Yuan Z J Immunol; 2013 May; 190(10):5142-51. PubMed ID: 23585678 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antigen impairs TLR4 signaling by upregulating A20 expression in monocytes. Wang C; Huang C; Li Y; Bai J; Zhao K; Fang Z; Chen J Microbiol Spectr; 2024 Oct; 12(10):e0090924. PubMed ID: 39248482 [TBL] [Abstract][Full Text] [Related]
9. Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma. Shi W; Su L; Li Q; Sun L; Lv J; Li J; Cheng B Tumour Biol; 2014 Oct; 35(10):9627-37. PubMed ID: 24964964 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus. Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844 [TBL] [Abstract][Full Text] [Related]
11. Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes. Haga Y; Kanda T; Nakamoto S; Nakamura M; Sasaki R; Wu S; Yokosuka O Biochem Biophys Res Commun; 2017 May; 486(3):858-863. PubMed ID: 28363866 [TBL] [Abstract][Full Text] [Related]
12. Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Kataki K; Borthakur P; Kumari N; Deka M; Kataki AC; Medhi S J Med Virol; 2017 Jun; 89(6):1008-1014. PubMed ID: 27769109 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth. Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus upregulates host expression of α-1,2-mannosidases Hu S; Jiang LB; Zou XJ; Yi W; Tian DY World J Gastroenterol; 2016 Nov; 22(43):9534-9543. PubMed ID: 27920474 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. Zhang F; Wang Q; Ye L; Feng Y; Zhang X J Med Virol; 2010 May; 82(6):920-8. PubMed ID: 20419804 [TBL] [Abstract][Full Text] [Related]
17. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells. Liu Y; Gao P Mol Med Rep; 2014 Dec; 10(6):3113-7. PubMed ID: 25270731 [TBL] [Abstract][Full Text] [Related]
18. Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro. Zhang R; Real CI; Liu C; Baba HA; Gerken G; Lu M; Broering R Int J Cancer; 2017 Jul; 141(2):354-363. PubMed ID: 28419472 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A. Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]